Opinion of Belgian neurologists on antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET)

Acta Neurologica Scandinavica

Volumn 115, Issue 2, 2007, Pages 97-103

  Legros, B ^a   Boon, P ^b   Dejonghe, P ^c   Sadzot, B ^d   Van Rijckevorsel, K ^e   Schmedding, E ^f  

^a ERASME HOSPITAL   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d CHU SART TILMAN   (Belgium)

^e Centre Neurologique William Lennox   (Belgium)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Antiepileptic drugs; Consensus; Epilepsy; Expert; Survey; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BELGIUM; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG INDICATION; EPILEPSY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; INTERVIEW; MEDICAL INFORMATION; MONOTHERAPY; MYOCLONUS SEIZURE; NEUROLOGY; PRACTICE GUIDELINE; PREGNANCY; PRESCRIPTION; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTICONVULSANTS; ATTITUDE OF HEALTH PERSONNEL; BELGIUM; CONSENSUS; EPILEPSY; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; NEUROLOGY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SEX FACTORS;

EID: 33845894967     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00748.x     Document Type: Article

References (23)

1. BEN MENACHEM E, SCHEEPERS B, STODIECK S. Epilepsy: from consensus to daily practice. Acta Neurol Scand Suppl 2003;180:5-15.
2. PATSALOS PN, FROSCHER W, PISANI F, VAN RIJN CM. The importance of drug interactions in epilepsy therapy. Epilepsia 2002;43:365-85.
3. BOON P, D'HAVE M, VAN WALLEGHEM P et al. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment. Epilepsia 2002;43:96-102.
4. FRENCH JA, KANNER AM, BAUTISTA J et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1252-60.
5. FRENCH JA, KANNER AM, BAUTISTA J et al. Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004;45:410-23.
6. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE. The diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical Guideline 20 October 2004. Available at: www nice org uk/CG020NICEguideline 2004.
7. FRENCH J, SMITH M, FAUGHT E, BROWN L. Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 1999;52:1540-5.
8. BEGHI E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 2004;3:618-21.
9. KAHN DA, DOCHERTY JP, CARPENTER D, FRANCES A. Consensus methods in practice guideline development: a review and description of a new method. Psychopharmacol Bull 1997;33:631-9.
10. BROOK RH, CHASSIN MR, FINK A, SOLOMON DH, KOSECO J, PARK RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 1986;2:53-63.
11. KARCESKI S, MORRELL M, CARPENTER D. The expert consensus guideline series: treatment of epilepsy. Epilepsy Behav 2001;2:A1-50.
12. BOON P, DEJONGHE P, LEGROS B, SADZOT B, VAN RIJCKEVORSEL K, SCHMEDDING E. Impact of reimbursement restrictions on the choice of antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET). Submitted in 2005.
13. MARSON AG, WILLIAMSON PR, CLOUGH H, HUTTON JL, CHADWICK DW. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 2002;43:505-13.
14. TUDUR SMITH C, MARSON AG, WILLIAMSON PR. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database Syst Rev 2001;CD001769.
15. PATSALOS PN, PERUCCA E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003;2:347-56.
16. BEGHI E, ANNEGERS JF. Pregnancy registries in epilepsy. Epilepsia 2001;42:1422-5.
17. BOON P, HAUMAN H, LEGROS B, SADZOT B, VAN RIJCKEVORSEL K, VAN ZANDYCKE M. Belgian consensus on recommendations for standards of care for women with epilepsy before, during and after pregnancy. Acta Neurol Belg 2004;104:6-12.
18. MORROW J, RUSSELL A, GUTHRIE E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8.
19. TOMSON T, BATTINO D, BONIZZONI E et al. EURAP: an international registry of antiepileptic drugs and pregnancy. Epilepsia 2004;45:1463-4.
20. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006;66:354-60.
21. ROWAN AJ, RAMSAY RE, COLLINS JF et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-73.
22. KRAUSS GL, SIMMONS-O'BRIEN E, CAMPBELL M. Successful treatment of seizures and porphyria with gabapentin. Neurology 1995;45:594-5.
23. TOMSON T, KENNEBACK G. Arrhythmia, heart rate variability, and antiepileptic drugs. Epilepsia 1997;38:S48-51.